000 01566 a2200445 4500
005 20250518021848.0
264 0 _c20200518
008 202005s 0 0 eng d
022 _a1090-2422
024 7 _a10.1016/j.yexcr.2019.01.019
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSheng, Zhiyong
245 0 0 _aCSN5 attenuates Ang II-induced cardiac hypertrophy through stabilizing LKB1.
_h[electronic resource]
260 _bExperimental cell research
_c03 2019
300 _a11-17 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAMP-Activated Protein Kinase Kinases
650 0 4 _aAMP-Activated Protein Kinases
650 0 4 _aAngiotensin II
_xpharmacology
650 0 4 _aAnimals
650 0 4 _aCOP9 Signalosome Complex
_xgenetics
650 0 4 _aCardiomegaly
_xgenetics
650 0 4 _aDisease Models, Animal
650 0 4 _aGene Expression Regulation
_xgenetics
650 0 4 _aHumans
650 0 4 _aMice
650 0 4 _aMyocytes, Cardiac
_xmetabolism
650 0 4 _aPeptide Hydrolases
_xgenetics
650 0 4 _aProtein Binding
_xgenetics
650 0 4 _aProtein Interaction Maps
_xgenetics
650 0 4 _aProtein Kinases
_xgenetics
650 0 4 _aProtein Serine-Threonine Kinases
_xgenetics
700 1 _aXu, Yun
700 1 _aLi, Fuxin
700 1 _aWang, Shu
700 1 _aHuang, Tieqiu
700 1 _aLu, Peng
773 0 _tExperimental cell research
_gvol. 376
_gno. 1
_gp. 11-17
856 4 0 _uhttps://doi.org/10.1016/j.yexcr.2019.01.019
_zAvailable from publisher's website
999 _c29320256
_d29320256